❆❜str❛❝t ✕ ❆ss❡ss✐♥❣ s♦❢t✇❛r❡ q✉❛❧✐t2 ❛ttr✐❜✉t❡s ✭s✉❝❤ ❛s ♣❡r❢♦r♠❛♥❝❡✱ r❡❧✐❛❜✐❧✐t2✱ ❛♥❞ s❡❝✉r✐t2✮ ❢r♦♠ s♦✉r❝❡ ❝♦❞❡ ✐s ♦❢ t❤❡ ✉t♠♦st ✐♠♣♦rt❛♥❝❡✳ ❚❤❡ ♣❡r❢♦r♠❛♥❝❡ ♦❢ ❛ s♦❢t✇❛r❡ s2st❡♠ ❝❛♥ ❜❡ ✐♠♣r♦✈❡❞ ❜2 ✐ts ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥✳ ❚❤❡ ❛✐♠ ♦❢ t❤❡ ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥ ✐s t♦ s♣❡❡❞ ✉♣ ❜2 ♣r♦✈✐❞✐♥❣ t❤❡ ♠❛1✐♠✉♠ ♣♦ss✐❜❧❡ ❝♦♥❝✉rr❡♥❝2 ✐♥ ❡1❡❝✉t✐♥❣ t❤❡ ❞✐str✐❜✉t❡❞ s❡❣♠❡♥ts✳ ■t ✐s ❛...

❆❜str❛❝t ✕ ❆ss❡ss✐♥❣ s♦❢t✇❛r❡ q✉❛❧✐t2 ❛ttr✐❜✉t❡s ✭s✉❝❤ ❛s ♣❡r❢♦r♠❛♥❝❡✱ r❡❧✐❛❜✐❧✐t2✱ ❛♥❞ s❡❝✉r✐t2✮ ❢r♦♠ s♦✉r❝❡ ❝♦❞❡ ✐s ♦❢ t❤❡ ✉t♠♦st ✐♠♣♦rt❛♥❝❡✳ ❚❤❡ ♣❡r❢♦r♠❛♥❝❡ ♦❢ ❛ s♦❢t✇❛r❡ s2st❡♠ ❝❛♥ ❜❡ ✐♠♣r♦✈❡❞ ❜2 ✐ts ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥✳ ❚❤❡ ❛✐♠ ♦❢ t❤❡ ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥ ✐s t♦ s♣❡❡❞ ✉♣ ❜2 ♣r♦✈✐❞✐♥❣ t❤❡ ♠❛1✐♠✉♠ ♣♦ss✐❜❧❡ ❝♦♥❝✉rr❡♥❝2 ✐♥ ❡1❡❝✉t✐♥❣ t❤❡ ❞✐str✐❜✉t❡❞ s❡❣♠❡♥ts✳ ■t ✐s ❛...

❆❜str❛❝t ✕ ❆ss❡ss✐♥❣ s♦❢t✇❛r❡ q✉❛❧✐t2 ❛ttr✐❜✉t❡s ✭s✉❝❤ ❛s ♣❡r❢♦r♠❛♥❝❡✱ r❡❧✐❛❜✐❧✐t2✱ ❛♥❞ s❡❝✉r✐t2✮ ❢r♦♠ s♦✉r❝❡ ❝♦❞❡ ✐s ♦❢ t❤❡ ✉t♠♦st ✐♠♣♦rt❛♥❝❡✳ ❚❤❡ ♣❡r❢♦r♠❛♥❝❡ ♦❢ ❛ s♦❢t✇❛r❡ s2st❡♠ ❝❛♥ ❜❡ ✐♠♣r♦✈❡❞ ❜2 ✐ts ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥✳ ❚❤❡ ❛✐♠ ♦❢ t❤❡ ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥ ✐s t♦ s♣❡❡❞ ✉♣ ❜2 ♣r♦✈✐❞✐♥❣ t❤❡ ♠❛1✐♠✉♠ ♣♦ss✐❜❧❡ ❝♦♥❝✉rr❡♥❝2 ✐♥ ❡1❡❝✉t✐♥❣ t❤❡ ❞✐str✐❜✉t❡❞ s❡❣♠❡♥ts✳ ■t ✐s ❛...

❆❜str❛❝t ✕ ❆ss❡ss✐♥❣ s♦❢t✇❛r❡ q✉❛❧✐t2 ❛ttr✐❜✉t❡s ✭s✉❝❤ ❛s ♣❡r❢♦r♠❛♥❝❡✱ r❡❧✐❛❜✐❧✐t2✱ ❛♥❞ s❡❝✉r✐t2✮ ❢r♦♠ s♦✉r❝❡ ❝♦❞❡ ✐s ♦❢ t❤❡ ✉t♠♦st ✐♠♣♦rt❛♥❝❡✳ ❚❤❡ ♣❡r❢♦r♠❛♥❝❡ ♦❢ ❛ s♦❢t✇❛r❡ s2st❡♠ ❝❛♥ ❜❡ ✐♠♣r♦✈❡❞ ❜2 ✐ts ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥✳ ❚❤❡ ❛✐♠ ♦❢ t❤❡ ♣❛r❛❧❧❡❧ ❛♥❞ ❞✐str✐❜✉t❡❞ ❡1❡❝✉t✐♦♥ ✐s t♦ s♣❡❡❞ ✉♣ ❜2 ♣r♦✈✐❞✐♥❣ t❤❡ ♠❛1✐♠✉♠ ♣♦ss✐❜❧❡ ❝♦♥❝✉rr❡♥❝2 ✐♥ ❡1❡❝✉t✐♥❣ t❤❡ ❞✐str✐❜✉t❡❞ s❡❣♠❡♥ts✳ ■t ✐s ❛...

Hepatocyte growth factor (HGF) exerts proliferative activities in thyrocytes upon binding to its tyrosine kinase receptor c-met and is also expressed in benign thyroid nodules as well as in Hashimoto's thyroiditis (HT). The simultaneous expression of HGF/c-met and three trasducers of tyrosine kinase receptors (STAT3, PI3K, RHO) in both the nodular and extranodular tissues were studied by immuno...

MicroRNA (miRNA) expression profiling has proven useful in diagnosing and understanding the development and progression of several diseases. Microarray is the standard method for analyzing miRNA expression profiles; however, it has several disadvantages, including its limited detection of miRNAs. In recent years, advances in genome sequencing have led to the development of next-generation seque...

BACKGROUND KRAS is one of commonly mutated genetic "drivers" in non-small cell lung cancers (NSCLCs). Recent studies indicate that patients with KRAS-mutated tumors do not benefit from adjuvant chemotherapy, so there is now a focus on targeting KRAS-mutated NSCLCs. A feasible mutation detection method is required in order to accurately test for KRAS status. METHODS We compared direct Sanger s...

Next generation sequencing (NGS) technologies have been rapidly applied in biomedical and biological research since its advent only a few years ago, and they are expected to advance at an unprecedented pace in the following years. To provide the research community with a comprehensive NGS resource, we have developed the database Next Generation Sequencing Catalog (NGS Catalog, http://bioinfo.mc...